Journal of Neuroimmunology logo Elsevier logo

Publisher: Elsevier

Related content
Volume 139, Number 1, June 2003

< previous issue | all issues | next issue >

Editorial Board
pp. iii-iii(1)

Vav1-deficient mice are resistant to MOG-induced experimental autoimmune encephalomyelitis due to impaired antigen priming
pp. 17-26(10)
Authors: Korn T.; Fischer K.-D.; Girkontaite I.; Kollner G.; Toyka K.; Jung S.

IL-1Rrp2 expression and IL-1F9 (IL-1H1) actions in brain cells
pp. 36-43(8)
Authors: Berglof E.; Andre R.; Renshaw B.R.; Allan S.M.; Lawrence C.B.; Rothwell N.J.; Pinteaux E.

Experimental autoimmune encephalomyelitis relapses are reduced in heterozygous golli MBP knockout mice
pp. 44-50(7)
Authors: Voskuhl R.R.; Pribyl T.M.; Kampf K.; Handley V.; Liu H.-b.; Feng J.; Campagnoni C.W.; Soldan S.S.; Messing A.; Campagnoni A.T.

Kinetics of CCR7 expression differ between primary activation and effector memory states of TH1 and TH2 cells
pp. 58-65(8)
Authors: Calabresi P.A.; Allie R.; Mullen K.M.; Yun S.H.; Georgantas R.W.; Whartenby K.A.

Antibodies to sulfatide in cerebrospinal fluid of patients with multiple sclerosis
pp. 76-80(5)
Authors: Ilyas A.A.; Chen Z.-W.; Cook S.D.

Interleukin-10 promoter polymorphisms in patients with Guillain-Barre syndrome
pp. 81-83(3)
Authors: Myhr K.-M.; Vagnes K.S.; Maroy T.H.; Aarseth J.H.; Nyland H.I.; Vedeler C.A.

Dynamics of immune cell trafficking in interferon-beta treated multiple sclerosis patients
pp. 84-92(9)
Authors: Hartrich L.; Weinstock-Guttman B.; Hall D.; Badgett D.; Baier M.; Patrick K.; Feichter J.; Hong J.; Ramanathan M.

An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis
pp. 93-101(9)
Authors: Emsley H.C.A.; Smith C.J.; Gavin C.M.; Georgiou R.F.; Vail A.; Barberan E.M.; Hallenbeck J.M.; del Zoppo G.J.; Rothwell N.J.; Tyrrell P.J.; Hopkins S.J.

Autoantibodies to IL-12 in myasthenia gravis patients with thymoma; effects on the IFN-gamma responses of healthy CD4+ T cells
pp. 102-108(7)
Authors: Zhang W.; Liu J.-L.; Meager A.; Newsom-Davis J.; Willcox N.

Microarray analysis identifies interferon beta-regulated genes in multiple sclerosis
pp. 109-118(10)
Authors: Koike F.; Satoh J.-i.; Miyake S.; Yamamoto T.; Kawai M.; Kikuchi S.; Nomura K.; Yokoyama K.; Ota K.; Kanda T.; Fukazawa T.; Yamamura T.

Effects on axonal conduction of anti-ganglioside sera and sera from patients with Guillain-Barre syndrome
pp. 133-140(8)
Authors: Dilley A.; Gregson N.A.; Hadden R.D.M.; Smith K.J.

GM1 antibodies in post-polio syndrome and previous paralytic polio
pp. 141-144(4)
Authors: Farbu E.; Rekand T.; Tysnes O.-B.; Aarli J.A.; Gilhus N.E.; Vedeler C.A.

Evidence for endogenous interleukin-10 during nociception
pp. 145-149(5)
Authors: Tu H.; Juelich T.; Smith E.M.; Tyring S.K.; Rady P.L.; Hughes T.K.

Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta
pp. 150-154(5)
Authors: Batocchi A.P.; Rotondi M.; Caggiula M.; Frisullo G.; Odoardi F.; Nociti V.; Carella C.; Tonali P.A.; Mirabella M.

Interferon beta promotes survival in primary astrocytes through phosphatidylinositol 3-kinase
pp. 155-159(5)
Authors: Barca O.; Ferre S.; Seoane M.; Prieto J.M.; Lema M.; Senars R.; Arce V.M.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page